SCHEMBL10340239

SCHEMBL10340239

COC(Cl)(C(=O)O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.54
CES1 P23141 1/20 0.48
KCNN4 O15554 1/20 0.48
CYP2D6 P10635 2/20 0.41
TSHR P16473 3/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP2C19 P33261 2/20 0.39
HIF1A Q16665 1/20 0.39
ALDH1A1 P00352 2/20 0.39
ALOX15 P16050 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38
HDAC2 Q92769 1/20 0.38
HDAC10 Q969S8 1/20 0.38
HDAC11 Q96DB2 1/20 0.38
HDAC8 Q9BY41 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31308059 0.81 OPRM1 (0.46) CYP1A2CES1KCNN4TSHRMAPT
SCHEMBL19437340 0.80 CYP1A2 (0.50) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL19437483 0.80 CYP1A2 (0.50) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL6557133 0.75 CES1 (0.44) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL1585516 0.74 CES1 (0.68) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL5130509 0.74 KCNN4 (0.52) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL340836 0.74 KCNN4 (0.52) CYP1A2CES1KCNN4CYP2D6TSHR
SCHEMBL8381914 0.73 CYP1A2 (0.40) CYP1A2CES1KCNN4TSHRKMT2A
SCHEMBL3435120 0.73 ALDH1A1 (0.47) CYP1A2CYP2D6TSHRKMT2ACYP2C19
SCHEMBL9291597 0.73 MEN1 (0.43) CYP1A2CES1KCNN4CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102557971-B Substituted acids for the treatment of respiratory diseases ASTRAZENECA AB 2015-06-17 CN disclosed
EP-0169537-B1 2-PHENYLALKYL-3-AMINOALKYL-4(3H)-QUINAZOLINONES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS AND USE MITSUBISHI KASEI CORPORATION (JP) 1990-01-03 EP disclosed
US-4668682-A CALCIUM ANTAGONISTS, VASODILATORS, HYPOTENSIVE AGENTS MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) 1987-05-26 US disclosed
EP-0169537-A2 2-Phenylalkyl-3-aminoalkyl-4(3H)-quinazolinones, processes for preparing them, pharmaceutical compositions and use MITSUBISHI KASEI CORPORATION (JP) 1986-01-29 EP disclosed